Abstract
An iron-catalyzed regioselective dicarbofunctionalization of electron-rich alkenes is described. In particular, aryl- and alkyl vinyl ethers are used as effective linchpins to couple alkyl or (fluoro)alkyl halides and sp2-hybrized Grignard nucleophiles. Preliminary results demonstrate ability to engage thioethers as lynchpins and control enantioselectivity in these transformations, an area which is largely unexplored for iron-catalyzed three-component cross-coupling reactions.
A three component iron-bisphospine-catalyzed regioselective dicarbofunctionalization of electron-rich alkenes is described.
Alkenes are prevalent motifs in natural products, pharmaceuticals, and represent valuable building blocks in organic synthesis (Scheme 1A).1 Recently, the difunctionalization of alkenes has attracted interest from the pharmaceutical community due to the potential for cost-effective, rapid, and modular synthesis of complex scaffolds.2 In this vein, transition metal-catalyzed three-component cross-coupling reactions have been used to selectively install functional groups across the alkene moiety, thereby building molecular complexity in one step.3,4,5,6,7,8,9,10,11 However, much of the efforts in the development of these reactions has been spent on electron-deficient alkenes and alkenes bearing directing groups to control reactivity and selectivity.12 As such, catalytic methods for the selective 1,2-dicarbofunctionalization of electron-rich alkenes are scarce13 and most are limited to the use of nickel or dual nickel/photoredox as catalysts (Scheme 1B).14,15,16,17
Scheme 1.
Transition-metal catalyzed 1,2-dicarbofunctionalization of electron-rich alkenes and its pharmaceutical relevance.
Seeking to continue to expand the utility of Fe-catalyzed multicomponent cross-couplings,18 we hypothesized that bisphosphine-iron complexes could serve as cost-effective, practical, and sustainable catalysts to promote regioselective 1,2-dicarbofunctionalization of electron-rich vinyl ethers and, if successful, could complement existing nickel and dual nickel/photoredox methods. Herein we report a three-component iron-catalyzed regioselective dicarbofunctionalization of aryl- and alkyl vinyl ethers that engage both alkyl halides and (fluoro)alkyl bromides with sp2-hybrized Grignard reagents (Scheme 1C). We expect that this method will find applications in the cost-effective synthesis of analogues of antidepressive drugs and, in particular, in the introduction of fluorine atoms into larger scaffolds with applications in pharmaceutical chemistry (Scheme 1A).19
Recently we developed an iron-catalyzed three-component radical cross-coupling using strain-release vinyl cyclopropanes as the conjunctive reagent under exceptionally rapid reaction times (< 1 hr).18a,18b Further, the reaction scope was extended to the use of unactivated alkenes without the use of directing groups.18c However, the main drawback of this method is the need for high concentration of alkene (i.e., as solvent) to drive the equilibrium towards the Giese addition adduct (i.e., alkyl radicals) for effective and subsequent cross-coupling with the presumed iron-aryl species. We hypothesized that Giese addition of alkyl radicals to vinyl ethers will lead to more stable α-oxy radicals and provide the driving force to ensure subsequent cross-coupling.
To test this hypothesis, we began our study of iron-catalyzed dicarbofunctionalization of vinyl ethers with the commercially available phenyl vinyl ether as the alkene linchpin (Table 1). To our delight, under excess alkene (14 equiv.), the desired three-component cross-coupling product 4 was formed with a 1,2-addition of the aryl Grignard and the alkyl group in high yield (89%; Table S1, entry 1). However, we sought to lower our alkene loading from 14 equivalents to increase the practical application of this method. Notably, we found that 4 equiv. of phenyl vinyl ether also gave reasonably high yield (75%; Table 1, entry 1) and we were able to recover 2.4 equiv. of the alkene after workup. Overall, under these conditions, effectively only 1.6 equiv. of phenyl vinyl ether is consumed in the reaction. Further, screening of various iron salts and ligands did not improve the yields (Table 1). Finally, control experiments verified that solvent, ligand, and iron catalyst were essential to the reactivity (see Tables S1 – S3 in the Supporting Information for full details of the reaction optimization.)
Table 1.
Evaluation of Reaction Conditions
![]() |
The reaction was performed with tert-butyl iodide 1a (0.1 mmol, 1.0 equiv), phenyl vinyl ether 2a (0.4 mmol, 4 equiv.) and 3-methoxyphenyl Grignard 3a (0.15 mmol, 1.5 equiv.). Aryl Grignard 3a was added dropwise via syringe pump over 1 h. The yield was determined by 1H NMR using dibromomethane as internal standard.
With the optimized conditions identified (Table 1, entry 1), we proceeded to study the generality of this iron-catalyzed dicarbofunctionalization reaction. Initially, we focused on examining the diversity of Grignard nucleophiles for this reaction (Scheme 2). Electron-rich Grignard reagents afforded products (4-8) in good yield while mildly electron-deficient Grignard reagents were tolerated as well, giving products (11, 12) in moderate yields. Notably, electron-poor Grignard reagents gave products (9,10,13) albeit in lower yields. Although meta- and para-substituted Grignard reagents alike afforded products, ortho-methoxy Grignard reagent was not compatible, presumably due to the increased steric hindrance between the ortho-substituent and the incipient alkyl component. Finally, to demonstrate the scalability of the method, we prepared 1.02 g of compound 4 (66% yield; 3.59 mmol).
Scheme 2.
Scope of Grignard nucleophile in the 3-component cross-coupling with tert-butyl iodide and phenyl vinyl ether. All reactions were performed under the optimized conditions (Table 1, entry 1) using 0.2 mmol tert-butyl iodide. Isolated yields are reported.
With the scope of Grignard reagent explored, the alkyl halide scope was then investigated (Scheme 3). In addition to the tert-butyl iodide used during the reaction screening, we found that 1-bromo- and 1-iodoadamantane (14, 15) and fluoroalkyl halides (16-20) were compatible in this transformation. Given that ~20% of drugs on the market contain at least one fluorine atom, this method shows promise for applications in pharmaceutical settings.20 In addition, 2-bromo-2-methylbutane successfully gave product in moderate yield (21, 51%). Finally, to highlight potential applications of an alkyl chloride as a viable radical precursor in multicomponent cross-coupling reactions, we used tert-butyl chloride as the alkyl halide and, gratifyingly, obtained product 22 in moderate yield (39%), albeit lower than when tert-butyl iodide was used as the alkyl halide (7, 56%, Scheme 2).
Scheme 3.
Scope of alkyl halides in the 3-component cross-coupling with phenyl vinyl ether and 4-biphenylmagnesium bromide 3b. All reactions were performed under the optimized conditions (Table 1, entry 1) using 0.2 mmol alkyl halide. Isolated yields are reported.
Finally, the alkene substrate scope was investigated (Scheme 4). Overall, attempts to extend the reaction to linear and branched alkyl vinyl ethers were modestly successful, giving products (23-28) in 29-42% yield. These results show that alkyl vinyl ethers, in addition to aryl vinyl ethers (30, 31) can function as effective linchpins in this three-component reaction. To highlight the potential expansion to thioethers, we used vinyl ethyl thioether as alternative π-acceptor and were pleased to observe the desired product in modest yield (29). Interestingly, even the internal alkene 3,4-dihydro-2H-pyran reacted in this method to give a moderate yield of product 32 as the trans isomer, as determined by NOESY (see Figure S4). The ability of this reaction to functionalize internal vinyl ethers opens the possibility for this method to be used in the formation of C-aryl glycosides from carbohydrate derivatives, thereby expanding the utility of this reaction. In aim to improve practicality of this method, we tested other vinyl ethers with more easily removed protecting groups but unfortunately these were not compatible in the reaction (see Figures S1 – S3 in the Supporting Information for full details).
Scheme 4.
Scope of vinyl ethers in the 3-component conjunctive cross-coupling with alkyl halides and 4-biphenylmagnesum bromide 3b or 4-phenoxyphenylmagnesum bromide 3c. All reactions were performed under the optimized conditions (Table 1, entry 1) using 0.2 mmol of alkyl halide. Isolated yields are reported.
Finally, using optimized reaction conditions, preliminary results show the potential for an enantioselective variant of this transformation (Scheme 5 and Table S4 in the Supporting Information). The development of enantioselective three-component radical cross-coupling reactions remains a considerable challenge in the field and currently is being pursued in our laboratories.21
Scheme 5.
Preliminary results on the asymmetric version of the 3-component conjunctive cross-coupling. The given yield is an isolated yield and the enantiomeric ratio was determined by chiral HPLC, both determined as an average of the results from four trials.
In summary, we have developed an iron-catalyzed regioselective 1,2-dicarofunctionalization of electron-rich alkenes with (fluoro)alkyl halides and aryl Grignard reagents. This reaction successfully gives product with both electron-donating aryl Grignard reagents and mildly electron-withdrawing aryl Grignard reagents. Further, we have shown that this method functionalizes both aryl and alkyl vinyl ethers. Notably, this method can introduce fluoroalkyl groups to a vinyl ether in a one-step synthesis, whereby molecular complexity for pharmaceutical applications can be rapidly increased. Ongoing work on the asymmetric variant of this reaction is currently underway in our laboratory and will be reported in due course.
Supplementary Material
Acknowledgments
This research was supported by the NSF (CAREER 1751568) and by the NIGMS of the NIH (R35GM137797).
Footnotes
Electronic Supplementary Information (ESI) available: [details of any supplementary information available should be included here]. See DOI: 10.1039/d1cc04619e.
There are no conflicts to declare.
References
- 1.Qi X and Diao T. ACS Catal. 2020, 10, 8542–8556. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Cao H, Liu H, and Domling A. Chem. Eur. J 2010, 16, 12296–12298. [DOI] [PubMed] [Google Scholar]
- 3.(a) Derosa J, Tran VT, van der Puyl VA, and Engle KM. Aldrichimica Acta, 2018, 51, 21–32. [Google Scholar]; (b) Giri R and KC S. J. Org. Chem. 2018, 83, 3013–3022. [DOI] [PubMed] [Google Scholar]; (c) Liao L, Jana R, Urkalan KB, and Sigman MS. J. Am. Chem. Soc, 2011, 133, 5784–5787. [DOI] [PMC free article] [PubMed] [Google Scholar]; (d) García-Domínguez A, Li Z, and Nevado C. J. Am. Chem. Soc, 2017, 139, 6835–6838. [DOI] [PubMed] [Google Scholar]
- 4.Tu H, Wang F, Huo L, Li Y, Zhu S, Zhao X, Li H, Qing F, and Chu L. J. Am. Chem. Soc 2020, 142, 9604–9611. [DOI] [PubMed] [Google Scholar]
- 5.Yan M, Lo JC, Edwards JT, and Baran PS. J. Am. Chem. Soc 2016, 138,12692–12714. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Campbell MW, Compton JS, Kelly CB, and Molander GA. J. Am. Chem. Soc 2019, 141, 20069–20078. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Qin T, Cornella J, Li C, Malins LR, Edwards JT, Kawamura S, Maxwell BD, Eastgate MD, and Baran PS. Science 2016, 352, 801–805. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Basnetm P, KC S, Dhungana RK, Shrestha B, Boyle TJ, and Giri R. J. Am. Chem. Soc 2018, 140, 15586–15590. [DOI] [PubMed] [Google Scholar]
- 9.For representative examples of Pd and Ni catalyzed conjunctive cross-couplings, refer to the following.; (a) Lovinger GJ and Morken JP. J. Am. Chem. Soc. 2017, 139, 17293–17296. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Derosa J, Kleinmans R, Tran VT, Karunananda MK, Wisniewski SR, Eastgate MD, and Engle KM. J. Am. Chem. Soc. 2018, 140, 17878–17883. [DOI] [PubMed] [Google Scholar]; (c) Lovinger GJ, Aparece MD, and Morken JP. J. Am. Chem. Soc. 2017, 139, 3153–3160. [DOI] [PMC free article] [PubMed] [Google Scholar]; (d) Edelstein EK, Namirembe S, and Morken JP. J. Am. Chem. Soc. 2017, 139, 5027–5030. [DOI] [PMC free article] [PubMed] [Google Scholar]; (g) Wu L, Wang F, Wan X, Wang D, Chen P, and Liu G. J. Am. Chem. Soc. 2017, 139, 2904–2907. [DOI] [PubMed] [Google Scholar]; (h) Lin J, Li T, Liu J, Jiao G, Gu Q, Cheng J, Guo Y, Hong X, and Liu X. J. Am. Chem. Soc. 2019, 141, 1074–1083. [DOI] [PubMed] [Google Scholar]; (i) Kadam AA, Metz TL, Qian Y, and Stanley LM. ACS Catal. 2019, 9, 5651–5656. [Google Scholar]; (j) Wang X, Lu X, He S, and Fu Y. Chem. Sci. 2020, 11, 7950–7956. [DOI] [PMC free article] [PubMed] [Google Scholar]; (k) Zhang Y, Chen G, and Zhao D. Chem. Sci. 2019, 10, 7952–7957. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Ni D and Brown MK. ACS Catal. 2021, 11, 1858–1862. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Xu S, Chen H, Zhou Z, and Kong W. Angew. Chem. Int. Ed 2021, 60, 7405–7411. [DOI] [PubMed] [Google Scholar]
- 12.Shu W, García-Domínguez A, Quiros MT, Mondal R, Cardenas DJ, and Nevado C. J. Am. Chem. Soc 2019, 141, 13812–13821. [DOI] [PubMed] [Google Scholar]
- 13.Qi X and Diao T. ACS Catal. 2020, 10, 8542–8556. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.(a) Granger BA, Wang Z, Kaneda K, Fang Z, and Martin SF. ACS Comb. Sci. 2013, 15, 379–386. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Li T, Liang K, Zhang Y, Hu D, Ma Z, and Xia C. Org. Lett. 2020, 22, 2386–2390. [DOI] [PubMed] [Google Scholar]; (c) Wang Q, Qu Y, Tian H, Liu Y, Song H, and Wang Q. Chem. Euro. J 2019, 25, 8686–8690. [DOI] [PubMed] [Google Scholar]
- 15.Guo L, Tu H, Zhu S, Chu L. Org. Lett, 2019, 21, 4771–4776. [DOI] [PubMed] [Google Scholar]
- 16.García-Domínguez A, Mondal R, and Nevado C. Angew. Chem. Int. Ed, 2019, 58, 12286–12290. [DOI] [PubMed] [Google Scholar]; (b) Shu W, García-Domínguez A, Quiros MT, Mondal R, Cardenas DJ, and Nevado C. J. Am. Chem. Soc 2019, 141, 13812–13821. [DOI] [PubMed] [Google Scholar]
- 17.Derosa J, Apolinar O, Kang T. Tran VT, and Engle KM. Chem. Sci, 2020, 11, 4287–4296. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.(a) Liu L, Lee W, Yuan M, Acha C, Geherty MB, Williams B, and Gutierrez O. Chem. Sci, 2020, 11, 3146–3151. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Liu L, Lee W, Zhou J, Bandyopadhyay S, and Gutierrez O. Tetrahedron, 2019, 75, 129–136. [Google Scholar]; (c) Liu L, Lee W, Youshaw CR, Yuan M, Geherty MB, Zavalij PY, and Gutierrez O, O. Chem. Sci 2020, 11, 8301–8305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Bauer I and Knölker H. Chem. Rev 2015, 115, 3170–3387. [DOI] [PubMed] [Google Scholar]
- 20.(a) Wang J, Sańchez-Roselló M, Aceña JL, del Pozo C, Sorochinsky AE, Fustero S, Soloshonok VA, and Liu H. Chem. Rev. 2014, 114, 2432–2506. [DOI] [PubMed] [Google Scholar]; (b) Hong CM, Whittaker AM, and Schultz DM. J. Org. Chem 2021, 86, 3999–4006. [DOI] [PubMed] [Google Scholar]
- 21.Tu H, Wang F, Huo L, Li Y, Zhu S, Zhao X, Li H, Qing F, and Chu L. J. Am. Chem. Soc 2020, 142, 9604–9611. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.